PFM Health Sciences’s Blackrock BLK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-166,775
Closed -$65.5M 98
2018
Q4
$65.5M Buy
+166,775
New +$68.3M 1.74% 24
2017
Q4
Sell
-45,330
Closed -$20.3M 81
2017
Q3
$20.3M Sell
45,330
-612
-1% -$261K 0.4% 70
2017
Q2
$19.4M Buy
+45,942
New +$18.3M 0.52% 59
2016
Q2
Sell
-189,158
Closed -$64.4M 82
2016
Q1
$64.4M Buy
189,158
+59,958
+46% +$19M 1.99% 21
2015
Q4
$44M Buy
+129,200
New +$43.9M 1.34% 30
2015
Q2
Sell
-165,831
Closed -$60.7M 93
2015
Q1
$60.7M Buy
165,831
+48,993
+42% +$17.8M 1.67% 24
2014
Q4
$41.8M Buy
+116,838
New +$39.9M 0.98% 35

Other funds holding BLK

PFM Health Sciences's BLK Position: Q1 2019 in Review

PFM Health Sciences sold out of Blackrock (BLK) in Q1 2019, closing a stake of 166,775 shares — an estimated $65.5M sold.

PFM Health Sciences first reported a position in BLK in Q4 2014 and held it in 7 quarters. The position peaked at $65.5M in Q4 2018. 1,267 funds tracked by Wall St. Rank hold BLK as of Q1 2019.

  • PFM Health Sciences reported no remaining Blackrock position as of Q1 2019 after selling out during the quarter.
  • PFM Health Sciences sold 166,775 Blackrock shares in Q1 2019, an estimated $65.5M.
  • PFM Health Sciences first reported a position in Blackrock in Q4 2014 and held it in 7 quarters.
  • PFM Health Sciences's Blackrock position peaked at $65.5M in Q4 2018.
  • 1,267 funds tracked by Wall St. Rank held Blackrock as of Q1 2019.

Based on PFM Health Sciences's 13F filing for Q1 2019, filed 15 May 2019.